ArticlePDF Available

Structural and Functional Characteristics of Two Sodium-coupled Dicarboxylate Transporters (ceNaDC1 and ceNaDC2) fromCaenorhabditis elegans and Their Relevance to Life Span

Authors:

Abstract

We have cloned and functionally characterized two Na+-coupled dicarboxylate transporters, namely ceNaDC1 and ceNaDC2, from Caenorhabditis elegans. These two transporters show significant sequence homology with the product of theIndy gene identified in Drosophila melanogasterand with the Na+-coupled dicarboxylate transporters NaDC1 and NaDC3 identified in mammals. In a mammalian cell heterologous expression system, the cloned ceNaDC1 and ceNaDC2 mediate Na+-coupled transport of various dicarboxylates. With succinate as the substrate, ceNaDC1 exhibits much lower affinity compared with ceNaDC2. Thus, ceNaDC1 and ceNaDC2 correspond at the functional level to the mammalian NaDC1 and NaDC3, respectively. Thenadc1 and nadc2 genes are not expressed at the embryonic stage, but the expression is detectable all through the early larva stage to the adult stage. Tissue-specific expression pattern studies using a reporter gene fusion approach in transgenic C. elegans show that both genes are coexpressed in the intestinal tract, an organ responsible for not only the digestion and absorption of nutrients but also for the storage of energy in this organism. Independent knockdown of the function of these two transporters inC. elegans using the strategy of RNA interference suggests that NaDC1 is not associated with the regulation of average life span in this organism, whereas the knockdown of NaDC2 function leads to a significant increase in the average life span. Disruption of the function of the high affinity Na+-coupled dicarboxylate transporter NaDC2 in C. elegans may lead to decreased availability of dicarboxylates for cellular production of metabolic energy, thus creating a biological state similar to that of caloric restriction, and consequently leading to life span extension.
Structural and Functional Characteristics of Two Sodium-coupled
Dicarboxylate Transporters (ceNaDC1 and ceNaDC2) from
Caenorhabditis elegans and Their Relevance to Life Span*
Received for publication, August 27, 2002, and in revised form, December 10, 2002
Published, JBC Papers in Press, December 11, 2002, DOI 10.1074/jbc.M208763200
You-Jun Fei‡§, Katsuhisa Inoue‡, and Vadivel Ganapathy‡
From the Departments of Biochemistry and Molecular Biology, and
Obstetrics and Gynecology,
Medical College of Georgia, Augusta, Georgia 30912
We have cloned and functionally characterized two
Na
-coupled dicarboxylate transporters, namely ceN
-
aDC1 and ceNaDC2, from Caenorhabditis elegans. These
two transporters show significant sequence homology
with the product of the Indy gene identified in Drosoph-
ila melanogaster and with the Na
-coupled dicarboxy
-
late transporters NaDC1 and NaDC3 identified in mam-
mals. In a mammalian cell heterologous expression
system, the cloned ceNaDC1 and ceNaDC2 mediate Na
-
coupled transport of various dicarboxylates. With succi-
nate as the substrate, ceNaDC1 exhibits much lower
affinity compared with ceNaDC2. Thus, ceNaDC1 and
ceNaDC2 correspond at the functional level to the mam-
malian NaDC1 and NaDC3, respectively. The nadc1 and
nadc2 genes are not expressed at the embryonic stage,
but the expression is detectable all through the early
larva stage to the adult stage. Tissue-specific expression
pattern studies using a reporter gene fusion approach in
transgenic C. elegans show that both genes are coex-
pressed in the intestinal tract, an organ responsible for
not only the digestion and absorption of nutrients but
also for the storage of energy in this organism. Inde-
pendent knockdown of the function of these two trans-
porters in C. elegans using the strategy of RNA interfer-
ence suggests that NaDC1 is not associated with the
regulation of average life span in this organism,
whereas the knockdown of NaDC2 function leads to a
significant increase in the average life span. Disruption
of the function of the high affinity Na
-coupled dicar
-
boxylate transporter NaDC2 in C. elegans may lead to
decreased availability of dicarboxylates for cellular pro-
duction of metabolic energy, thus creating a biological
state similar to that of caloric restriction, and conse-
quently leading to life span extension.
Two different Na
-coupled dicarboxylate transporters
(NaDC)
1
have been identified in mammalian tissues (1–7).
These are NaDC1 and NaDC3. NaDC1 is Na
-coupled, electro
-
genic, and exhibits low affinity for its dicarboxylate substrates.
The K
t
value (Michaelis-Menten constant) is in the range of
0.1– 4.0 m
M (1–4). This isoform is expressed primarily in the
brush border membrane of intestinal and renal epithelial cells.
The physiological function of NaDC1 is to absorb the interme-
diates of the citric acid cycle, such as citrate, succinate,
-ke-
toglutarate, fumarate, and malate, in the intestine and kidney.
NaDC3 is also a Na
-coupled and electrogenic dicarboxylate
transporter, but it exhibits relatively higher affinity for its
substrates compared with NaDC1 (5–7). The K
t
value is in
micromolar range. The NaDC3 is expressed primarily in the
basolateral membrane of intestinal and renal epithelial cells.
However, it is also found in tissues such as liver, placenta, and
brain. NaDC3 in the kidney is involved in generating the driv-
ing force for the organic anion transporter OAT1 to facilitate
the active entry of organic anions into the tubular cells across
the basolateral membrane (8). In the brain, NaDC3 mediates
the cellular uptake of N-acetylaspartate, a process closely
linked to myelination (9). Therefore, the physiological functions
of the NaDCs may extend beyond the mediation of cellular
entry of citric acid cycle intermediates. Recently, we reported
on the molecular identification of the third member of this
family in mammals (10, 11). This transporter, known as Na
-
coupled citrate transporter (NaCT), mediates the cellular up-
take of citrate in a Na
-coupled manner.
In a recent study by Rogina et al. (12), a NaDC-like trans-
porter, coded by the Indy (for I am not dead yet) gene, has been
implicated in the regulation of life span in Drosophila. The
investigators of this study suggested that defects in one copy of
the Indy gene (heterozygosity) can lead to less efficient produc-
tion of cellular energy and that, as a consequence, the meta-
bolic profile of the fruit fly changes resulting in life span ex-
tension. The eating behavior of the organism is not altered,
however. The decreased generation of cellular energy due to
the heterozygous mutation in the Indy gene creates a biological
situation resembling that of caloric restriction, which in other
animal models leads to an extension of life span (13). Recently,
we have identified (14) the transport function of Drosophila
INDY. This transporter mediates the cellular uptake of a broad
spectrum of citric acid cycle intermediates in a Na
-independ
-
ent manner. These characteristics of drINDY have now been
confirmed independently by Knauf et al. (15).
Studies of life span extension are difficult, if not impossible,
to conduct in mammals, particularly in humans. But it is
relatively a simple task to monitor the mean and maximum life
span in other animal models such as Caenorhabditis elegans.A
number of features make C. elegans especially suitable for
studies of life span extension. This organism has a short life
span with a mean life span of 15 days. In addition, there are
* This work was supported by National Institutes of Health Grants
DA10065 and HD33347 (to V. G.) and by an intramural grant from the
Medical College of Georgia Research Institute (to Y. J. F.). The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. E-mail: yjfei@mail.
mcg.edu.
1
The abbreviations used are: NaDC, Na
-coupled dicarboxylate
transporters; NaCT, Na
-coupled citrate transporter; ceNaDC, C. el
-
egans NaDC; hNaDC, human NaDC; hNaCT, human NaCT; drINDY,
Drosophila INDY; RT, reverse transcriptase; GFP, green fluorescent
protein; HRPE, human retinal pigment epithelial; NMDG, N-methyl-
D-glucamine; dsRNA, double-stranded RNA; YFP, yellow fluorescent
protein; CFP, cyan fluorescent protein; RNAi, RNA interference.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 8, Issue of February 21, pp. 6136 –6144, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org6136
by guest on December 22, 2015http://www.jbc.org/Downloaded from
techniques available to silence genes in this organism as a
means of assessing the role of specific genes in the maintenance
of life span. Therefore, with an aim to investigate the potential
role of NaDC family in life span, we set out to clone the
C. elegans counterparts of mammalian NaDCs and subse-
quently to monitor the influence of these transporters on life
span by using the RNAi technique to down-regulate their func-
tion. These studies have successfully led to the molecular and
functional identification of two different Na
-coupled dicar
-
boxylate transporters (ceNaDC1 and ceNaDC2) analogous to
the mammalian NaDC1 and NaDC3. In addition, studies of the
influence of these two transporters on life span have shown
that disruption of the function of the high affinity transporter
ceNaDC2, but not that of the low affinity transporter ceNaDC1,
leads to a significant extension of the average life span in
C. elegans.
EXPERIMENTAL PROCEDURES
Nematode Culture— A wild type nematode strain, C. elegans N2
(Bristol-Myers Squibb Co.), was obtained from the Caenorhabditis Ge-
netics Center (St. Paul, MN). Nematode culture was carried out using a
standard procedure with a large scale liquid cultivation protocol (16
19). The nematodes were cleaned by sedimentation through 15% (w/v)
Ficoll 400 in 0.1 M NaCl. The pellet was then used for total RNA
preparation.
Extraction and Purification of Poly(A)
RNA—Total RNA was iso
-
lated using the TRIzol reagent (Invitrogen). Poly(A)
mRNA was puri
-
fied by affinity chromatography using oligo(dT)-cellulose.
Reverse Transcription (RT)-PCR and Hybridization Probe Prepara-
tion—A pair of PCR primers specific for the putative C. elegans nadc1
gene was designed based on the sequence of the cosmid F31F6.6 (Gen-
Bank
TM
accession number Z69884), 5-GCC TCC AAG CAA AAT GTC
TC-3 (forward primer) and 5-CTA ACG CAA ATC CAC CTC C-3
(reverse primer). A second pair of PCR primers specific for putative C.
elegans nadc2 gene was designed based on the sequence of the cosmid
K08E5.2 (GenBank
TM
accession number Z30974), 5-TCA TCC TTC
CAA CAC CAT CC-3 (forward primer) and 5-ACC ATT CCA CTT CCA
AAC AC-3 (reverse primer). Poly(A)
RNA (0.5
g) isolated from
mixed stage C. elegans was taken as template to perform RT-PCR using
an RT-PCR kit from PerkinElmer Life Sciences. A single RT-PCR
product was obtained with an estimated size of 1.0 and 0.9 kb for the
cenadc1 and the cenadc2 genes, respectively, as predicted by the dis-
tance between the two primers in each pair. The RT-PCR products were
gel-purified and subcloned into pGEM-T Easy Vector (Promega, Madi-
son, WI). The molecular identity of the inserts was established by
sequencing. These cDNA fragments were used as probes to screen a
C. elegans cDNA library.
Construction of a Directional C. elegans cDNA Library—The Super-
Script Plasmid System from Invitrogen was used to establish the cDNA
library using the poly(A)
RNA from C. elegans. The transformation of
the ligated cDNA into Escherichia coli was performed by electropora-
tion using ElectroMAX DH10B competent cells. The bacteria plating,
the filter lifting, the DNA fragment labeling, and the hybridization
methods followed the routine procedure (20). The DNA sequencing of
the full-length ceNaDC1 cDNA and ceNaDC2 cDNA clones was per-
formed using an automated PerkinElmer Life Sciences Applied Biosys-
tems 377 Prism DNA sequencer and the Taq DyeDeoxy terminator
cycle sequencing protocol.
Vaccinia/T7 Expression System—Functional expression of the ceN-
aDC cDNAs in mammalian cells was done in human retinal pigment
epithelial (HRPE) cells using the vaccinia virus expression system as
described previously (5, 7, 9). HRPE cells grown in 24-well plates were
infected with a recombinant vaccinia virus (VTF
73
) at a multiplicity of
10 plaque-forming units/cell. The virus was allowed to adsorb for 30 min
at 37 °C with gentle shaking of the plate. Cells were then transfected
with the plasmid DNA (empty vector pSPORT or ceNaDC1 cDNA or
ceNaDC2 cDNA constructs) using the lipofection procedure (Invitro-
gen). The cells were incubated at 37 °C for 12 h and then used for
determination of transport activity. Cells transfected with pSPORT
alone without the cDNA insert were used as the control to determine
endogenous transport activity in these cells. [
3
H]Succinate uptake was
determined at 37 °C as described previously (5, 7, 9). In most experi-
ments, the uptake medium was 25 m
M Hepes/Tris (pH 7.5), containing
140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl
2
, 0.8 mM MgSO
4
,and5mM
glucose. In experiments in which the cation and anion dependence of
the transport process was investigated, NaCl was replaced iso-osmoti-
cally by LiCl, KCl, sodium gluconate, or N-methyl-
D-glucamine
(NMDG) chloride. The transport activity in cDNA-transfected cells was
adjusted for the endogenous activity to calculate the ceNaDC
cDNA-specific activity. The endogenous succinate transport activity in
vector-transfected cells was always less than 10% compared with the
succinate transport activity measured in cells transfected with either
ceNaDC1 cDNA or ceNaDC2 cDNA. Experiments were done in tripli-
cate, and each experiment was repeated at least three times. Results
are presented as means S.E.
Semi-quantitative RT-PCR—An RT-PCR assay with the cenadc1-or
cenadc2-specific primers described above was used to study the devel-
opmental stage-specific expression pattern of ceNaDC1 mRNA and
ceNaDC2 mRNA. A Quantum RNA 18 S internal standard (Ambion,
Austin, TX) was used for the semi-quantitative RT-PCR. Total RNA
(1.0
g) isolated from different developmental stages of C. elegans
(embryo, early larva, late larva, and adult) was taken as template to
perform reverse transcription using an RT-PCR kit from PerkinElmer
Life Sciences. The reverse transcription was initiated with random
hexamers and carried out in a DNA thermal cycler (GeneAmp PCR
System 9600) and thin-walled reaction tubes (PerkinElmer Life Sci-
ences) at 42 °C for 60 min, followed by incubation at 99 °C for 5 min to
inactivate the reverse transcriptase (Maloney murine leukemia virus-
reverse transcriptase). Reverse transcription was followed by PCR in a
multiplex format, in which the gene-specific primers and the primers
for the internal control (18 S rRNA) with their competimers were com-
bined at a predefined ratio. The PCR cycle number was titrated accord-
ing to the manufacturers protocol to ensure that the reaction was
within the linear range. A competimer was included to prevent the
highly abundant rRNA from being overwhelmingly amplified during
the reaction, and an optimal 18 S primer:competimer ratio was also
pre-established by trial and error. The resultant multiplex PCR prod-
ucts were resolved in an 1.0% agarose gel, and the intensity of the
gene-specific and the 18 S rRNA-specific bands was determined using
SpectraImager 5000 Imaging system and AlphaEase 32-bit software
(Alpha Innotech, San Leandro, CA). The steady state levels of ceNaDC1
mRNA and ceNaDC2 mRNA at different developmental stages were
assessed from the relative ratios of the intensity of the ceNaDC1-
specific RT-PCR product or ceNaDC2-specific RT-PCR product to the
intensity of the 18 S rRNA-specific RT-PCR product at each of these
stages.
Analysis of Tissue-specific Expression Pattern of cenadc1 and cen-
adc2—To study the tissue-specific expression pattern of the nadc1 and
nadc2 genes in C. elegans, transcriptional cenadc1::gfp and
cenadc2::gfp fusion genes were constructed, and transgenic animals
expressing these transgenes were developed. The expression pattern of
the cenadc1 and cenadc2 genes was investigated in live transgenic
animals based on the expression pattern of the GFP reporter. A pair of
primers for construction of a transcriptional cenadc1::gfp fusion gene
was designed to amplify the cenadc1 promoter. The forward primer,
5-CGC GTC GAC GCT TAC ATC ATT CTT GTA TTT TTC-3, corre-
sponds to the nucleotide positions 28,630 28,659 of the cosmid F31F6
(GenBank
TM
accession number Z69884). The primer contains an incor
-
porated SalI restriction site at its 5 end. The reverse primer, 5-ATA
GGA TCC ATG ATT GGA GGC TCT GCA ATA CTA-3, corresponds to
the nucleotide positions 29,79729,772 in the same cosmid. A BamHI
site was incorporated in this primer at the 5 end. The SalI and BamHI
sites were introduced into these primers for subsequent cloning into a
GFP expression vector. An 1.2-kb DNA fragment of the cenadc1
promoter was amplified using the cosmid F31F6 DNA as template.
Similarly, a pair of primers for construction of a transcriptional
cenadc2::gfp fusion gene was also designed. The forward primer, 5-
GTC GAC AAA ATA TGT ATT AGC CAC ATA AAA CCC-3, corre-
sponds to the nucleotide positions 13,96613,998 of the cosmid K08E5
(GenBank
TM
accession number Z30974). The reverse primer, 5-GGA
TCC ATT TTC CGC ACA TGC CGA ATT TGC AT-3, corresponds to the
nucleotide positions 15,46115,432 in the same cosmid. A SalI site and
a BamHI site were incorporated in these primers for subsequent sub-
cloning purposes. A 1.5-kb DNA fragment of the cenadc2 promoter
was amplified using the cosmid K08E5 as template. The PCR products
were digested with SalI and BamHI and inserted into a GFP expression
vector pPD117.01 (a generous gift from Dr. A. Fire, Carnegie Institu-
tion, Baltimore, MD) at a SalI/BamHI site. In these minigene con-
structs, a built-in mec7 promoter (0.9 kb) in the expression vector was
replaced by the cenadc1 and cenadc2 promoter fragments in such a way
that the GFP transcription is under control of the putative promoters of
the cenadc1 and cenadc2 genes, respectively. The minigene fusion con-
structs were verified by sequence analysis. Transgenic lines were es-
Sodium-coupled Dicarboxylate Transporters in C. elegans 6137
by guest on December 22, 2015http://www.jbc.org/Downloaded from
tablished using a standard germ line transformation protocol (17, 18).
Syncytial gonad injection was carried out according to a standard pro-
cedure (18). For microinjection, a computerized injection system, Trans-
jector 5246 and Micromanipulator 5171 from Eppendorf (Hamburg,
Germany), and a Nikon Eclipse TE 300 inverted microscope with No-
marski differential interference contrast optics were used. A cloned
mutant collagen gene containing the rol-6 (plasmid pRF4, kindly pro-
vided by Dr. M. Koelle, Yale University School of Medicine, New Haven,
CT) was used as a dominant genetic marker for DNA transformation.
Coinjection of this dominant marker with the GFP fusion constructs
allowed progeny selection of the transformed animals by their roller
phenotype. The F1 rollers were picked up according to their character-
istic rolling behavior and cultured individually to establish transformed
lines. F2 rollers with extrachromosome arrays were selected for fluo-
rescence microscopy to determine the GFP expression pattern. Stable
transgenic lines were established by the
-irradiation method from the
F2 rollers, and the background was cleaned up by several times of
outcross (17, 21).
Double Labeling Fluorescent Protein Expression SystemTwo mod-
ified versions of the Aequora victoria green fluorescent protein (GFP),
designated as CFP and YFP with cyan-shifted and yellow-shifted spec-
tra (22), respectively, were used to simultaneously follow the expression
patterns of ceNaDC1 and ceNaDC2 in C. elegans. For the construction
of the cenadc1 promoter-driven CFP and the cenadc2 promoter-driven
YFP expression vectors, the GFP coding region in the GFP-expression
vector cenadc1::gfp (pPD117) and cenadc2::gfp (pPD117) was substi-
tuted by the CFP and YFP coding regions, respectively. The CFP and
YFP coding regions (950 bp) were obtained by an EcoRI/KpnI diges-
tion of the vectors L4666 (pPD133.58) and L4664 (pPD133.51), respec-
tively (kindly provided by Dr. A. Fire, Carnegie Institution, Baltimore,
MD). The cenadc1::cfp and cenadc2::yfp expression vectors were linear-
ized by SalI digestion and coinjected into the distal arms of the
C. elegans syncytial gonads as described earlier. The extrachromosome
arrays were used for fluorescence microscopy to compare the expression
pattern of CFP and YFP in the same transgenic animal. Epi-fluores-
cence microscopic analysis of the expression of CFP and YFP was
performed using an Axiophot microscope (Carl Zeiss, Thornwood, NY).
Excitation and emission filter settings are as follows: for CFP exami-
nation, excitation at 436 20 nm, dichroic 455 nm LP, and emission at
480 40 nm; for YFP examination, excitation at 500 20 nm, dichroic
515 nm LP, and emission at 535 30 nm LP (22). The filter sets were
purchased from Chroma Technology (Brattleboro, VT). The SPOT-
cooled CCD color digital camera (Diagnostic Instruments Inc., St. Ster-
ling Heights, MI) and its associated data acquisition software were used
to record the fluorescence images.
Bacteria-mediated RNA Interference (RNAi) A fragment of the
coding region of ceNaDC1 cDNA was generated by PCR and subcloned
into a pGEM-T easy vector (Promega, Madison, WI). The DNA fragment
was released by EcoRI digestion and inserted into a double T7 plasmid
(pPD129.36, a generous gift from Dr. A. Fire, Carnegie Institution,
Baltimore, MD) at an EcoRI site within the multiple cloning site. A host
strain DH5
was used for the first transformation. Competent host
bacteria HT115 (DE3) (kindly provided by the Caenorhabditis Genetics
Center, St. Paul, MN)) expressing T7-RNA polymerase from an induc-
ible promoter was prepared using a standard CaCl
2
method (20). The
double T7 promoter-containing plasmid with the cenadc1 gene-specific
DNA fragment inserted between the two T7 promoter regions was
transformed into the competent HT115 (DE3) cells and plated onto
standard LB tetracycline (12.5
g/ml) ampicillin (100
g/ml)
plates. HT115 cells harboring the double-T7 plasmid were cultured and
induced to express dsRNA using 0.4 mM isopropyl-
-D-1-thiogalactopy-
ranoside at 37 °C for 4 h. The experimental worms were transferred
onto isopropyl-
-D-1-thiogalactopyranoside-containing nematode
growth medium plates with the induced bacteria HT115 lawn for bac-
teria feeding experiments. The empty vector pPD129 was processed
similarly for use as a negative control, and the bacteria harboring this
plasmid were used to feed the control worms. Sufficient quantities of
bacteria HT115 were seeded on the testing plates for the worms to
consume to prevent the worms from starving and to ensure that dsRNA
was always present in the testing plates during the entire experimental
period for the experimental worms. A similar experimental strategy
was used for ceNaDC2. To serve as a positive control for the bacteria-
mediated RNAi in the assessment of the influence of ceNaDC1 and
ceNaDC2 on life span, we monitored the influence of DAF-2 on life span
using an identical experimental approach. Homozygous daf-2
/
knockout in C. elegans is known to enhance the life span dramatically
(2-fold) (23, 24). Therefore, if the knockdown of DAF-2 function by
bacteria-mediated RNAi in C. elegans doubles the life span, this can be
taken as a positive control for the validity of the experimental approach
to assess the role of ceNaDC1 and ceNaDC2 in life span. For this
purpose, we obtained an 0.8-kb DNA fragment specific for C. elegans
DAF-2 by RT-PCR using the following primer pairs: 5-CGAACAAAA-
CACATCACAGAC-3 (forward primer) and 5-TCCATCATTTCCATCA-
CAACC-3 (reverse primer) using the nematode total RNA as the tem-
plate. This fragment was then subcloned into pGEM-T easy vector. The
fragment was then released from the vector by EcoRI digestion, and the
released insert was cloned into the double T7 plasmid pPD129.36 at the
EcoRI site at the multiple cloning region. Shuttling of this plasmid into
HT115 (DE3) bacteria, induction of double-stranded RNA, and feeding
of the worms with the bacteria were carried out as described earlier.
Life Span Measurement Life span of age-synchronous nematodes
was determined at 20 °C. Eggs obtained from gravid hermaphrodites
using an alkaline hypochlorite treatment procedure (18) were dispensed
on nematode growth medium Petri dishes with bacteria lawn and
allowed to hatch. Worms were inspected every day until death and were
scored as dead when they were no longer able to move even in response
to prodding with a platinum-wire pick. Each day, dead worms were
removed from plates and the deaths were recorded. Experiments were
started with 60 worms for each RNAi treatment (10 per plate). The
worms were transferred to a new plate every day during the reproduc-
tive period and every 3 days afterward to avoid contamination by their
offspring. Worms that died from matricidal hatching (the bag-of-worms
phenotype) and the worms that crawled off the plates or burrowed into
the agar were replaced by spare worms. A backup reservoir plate of 30
spare worms was started at the same time as the experimental worms
and was identically treated for this purpose. To avoid the influence of
any potential subjective judgment of the experimenter in identifying
the dead worms on the experimental outcome, the life span measure-
ment studies were repeated with the experimenter blinded with regard
to the identity of the individual experimental groups. Statistical anal-
ysis was performed using the Microsoft EXCEL 2000 analysis ToolPak.
Mean life spans from different groups were compared using the Stu-
dents t test assuming unequal population variances.
RESULTS
Molecular Cloning and Structural Characterization of ceN-
aDC1 and ceNaDC2The cloned ceNaDC1 cDNA is 1,989 bp
long and contains a poly(A) tail (GenBank
TM
accession number
AY090484). The 5- and 3-untranslated regions of this cDNA
are 12 and 173 bp long, respectively. The ceNaDC1 protein,
deduced from the coding region of the cDNA, contains 582
amino acids (Fig. 1) with a predicted molecular mass of 64 kDa
and an isoelectric point of 6.64. The ceNaDC2 cDNA is 2,250 bp
long and contains a poly(A) tail (GenBank
TM
accession number
AY090485). The 5- and 3-untranslated regions of this cDNA
are 50 and 500 bp long, respectively. The ceNaDC2 protein,
deduced from the coding region of the cDNA, contains 566
amino acids (Fig. 1) with a predicted molecular mass of 62 kDa
and an isoelectric point of 7.69. According to the Kyte-Doolittle
plot with a 21-amino acid window size, ceNaDC1 as well as
ceNaDC2 possess 12 putative transmembrane domains.
Following a multiple protein sequence alignment of the two
ceNaDCs, the three members of the human NaDC family, and
the drINDY using the PILEUP and in combination with the
MOTIFS program in the GCG package, a sodium symporter
family signature motif was identified within these transporter
proteins (Fig. 1). A consensus pattern established for the sig-
nature sequence is as follows: (S)SX(2)FX(2)P(V)(G)X(3)NX-
(I)V, where the X denotes the flexible amino acid residues
preceding the number in parentheses, and the numerical value
indicates the permitted number of the flexible amino acid res-
idues in the consensus. This sodium symporter family is a
group of integral membrane proteins that mediate the cellular
uptake of a wide variety of molecules including di- or tricar-
boxylates and sulfate by a transport mechanism involving so-
dium cotransport (sodium symporters). They are grouped into a
single gene family on the basis of sequence and functional
similarities. This group consists of the following proteins: the
sodium/sulfate cotransporters and sodium/dicarboxylate co-
transporters identified in yeast, C. elegans, Drosophila, and
Sodium-coupled Dicarboxylate Transporters in C. elegans6138
by guest on December 22, 2015http://www.jbc.org/Downloaded from
mammals; the putative sulfur deprivation response regulator
(SAC1) from Chlamydomonas reinhardtii; and the hypothet-
ical protein YfbS from E. coli (25). These transporter proteins
usually consist of 430 620 amino acids. They are highly
hydrophobic and contain 11 or 12 putative transmembrane
regions. The highly conserved sodium symporter signature
motif is located in or near the penultimate transmembrane
domain.
The molecular identity of mammalian or C. elegans func-
tional counterpart of drINDY is not known at present. There-
fore, we compared the primary structure of ceNaDC1 and ce-
NaDC2 with that of drINDY and mammalian NaDC1, NaDC3,
and NaCT. With a pairwise comparison analysis, ceNaDC1 is
more closely related to drINDY (51% similarity and 37% iden-
tity) than ceNaDC2 (46% similarity and 35% identity). Simi-
larly, hNaDC1 and hNaCT are more closely related to drINDY
(52% similarity and 40% identity) than hNaDC3 (50% similar-
ity and 37% identity). However, the differences are small, and
it is difficult to conclude whether ceNaDC1 or ceNaDC2 is the
C. elegans functional counterpart of drINDY based on the
structural comparison. Similarly, this structural analysis does
not allow definitive conclusion with regard to the question of
whether NaDC1or NaDC3 is the mammalian functional coun-
terpart of drINDY. Structural comparison reveals that both
ceNaDCs have similar sequence homology with hNaDC1,
hNaDC3, and hNaCT. Thus, the sequence data have failed to
provide any useful hint with respect to the functional identity
of the two ceNaDCs.
The cenadc1 and cenadc2 genes are located on chromosomes
X and III, respectively. Both genes, excluding the unidentified
promoter region in respective genes, are 3.5 kbp in size (C.
elegans data base, ACeDB, data version WS57). The presence of
10 exons in the cenadc1 gene and 8 exons in cenadc2 gene was
deduced by a comparison between the sequences of the cloned
cDNAs and the respective genes in the GenBank
TM
data base
(F31F6.6 and K08E5.2) from the nematode genome sequence
project. The structural organization of the cenadc1 and cenadc2
genes is shown in Fig. 2.
Functional Characterization of ceNaDC1 and ceNaDC2 Us-
ing a Heterologous Expression SystemThe functional analysis
of the cloned ceNaDCs was carried out by heterologous expres-
sion of the cDNAs in HRPE cells using the vaccinia virus
expression system (5, 7, 9). Cells transfected with vector alone
served as the control. The transport function was monitored by
the uptake of [
3
H]succinate. Initial studies on the time course
of uptake indicated that the uptake was linear at least up to 5
min. All subsequent studies were therefore carried out with a
2-min incubation. With a succinate concentration of 10
M and
in the presence of Na
, the uptake of succinate increased
12-fold in cells expressing ceNaDC1 compared with control
cells (Fig. 3A). Under similar conditions, the increase in succi-
nate uptake was 24-fold in the case of ceNaDC2. Thus, both
FIG.1. A multiple protein sequence comparison of the representative members in the NaDC superfamily. The software PILEUP
(version 10.2) in the GCG package (from the Genetic Computer Group Inc., Madison, WI) was used to establish this multiple sequence alignment.
Gaps are introduced to make an optimum alignment and are indicated by dots/dashes. The names of the transporters are indicated at the
beginning of the protein sequence. The sodium/symporter family signature sequence is highlighted by a box.
Sodium-coupled Dicarboxylate Transporters in C. elegans 6139
by guest on December 22, 2015http://www.jbc.org/Downloaded from
ceNaDC1 and ceNaDC2 mediate the uptake of succinate in the
presence of Na
. The uptake via these two transporters was,
however, obligatorily dependent on the presence of Na
be
-
cause substitution of Na
with Li
,K
, or NMDG abolished
completely the cDNA-induced increase in succinate uptake.
There was no involvement of anions in the uptake process as
indicated by comparable uptake activities for both transporters
in the presence of NaCl or sodium gluconate (data not shown).
The substrate selectivity of the uptake process mediated by
ceNaDCs was then studied by competition analysis by moni-
toring the ability of various monocarboxylates and dicarboxy-
lates (5 m
M) to compete with succinate for the uptake process
(Fig. 3B). Uptake measurements were made in parallel in
vector-transfected cells and in cDNA-transfected cells, and
then the cDNA-specific uptake was calculated by subtracting
the uptake in vector-transfected cells from the uptake in
cDNA-transfected cells. Only the cDNA-specific uptake was
used in the analysis. Among the various dicarboxylates tested,
the ceNaDC1-mediated succinate uptake was inhibited mark-
edly by fumarate, malate,
-ketoglutarate, dimethylsuccinate,
and N-acetylaspartate. In contrast to fumarate, its stereoiso-
mer maleate failed to compete with succinate for transport via
ceNaDC1. Malonate, a structural homolog of succinate, not
only failed to inhibit the uptake of succinate but actually
caused a significant stimulation of succinate uptake. The
monocarboxylates pyruvate, lactate, and
-hydroxybutyrate
caused only a minimal inhibition of succinate uptake.
The substrate selectivity of ceNaDC2 was more or less sim-
ilar to that of ceNaDC1. The uptake of succinate mediated by
ceNaDC2 was inhibited significantly by fumarate, malate,
-ketoglutarate, dimethylsuccinate, and N-acetylaspartate,
whereas the monocarboxylates had only a minimal effect. How-
ever, there were some notable differences between ceNaDC1
and ceNaDC2. Maleate was able to inhibit ceNaDC2-mediated
succinate uptake, whereas ceNaDC1-mediated succinate up-
take was not affected. Malonate, which caused a significant
stimulation of succinate uptake via ceNaDC1, had minimal
effect on succinate uptake via ceNaDC2. Another notable fea-
ture was that fumarate and malate were much more potent in
inhibiting ceNaDC2-mediated succinate uptake than in inhib-
iting ceNaDC1-mediated succinate uptake, suggesting that
there may be significant differences in substrate affinities be-
tween the two transporters. But, interestingly the trend in the
inhibitory potency was opposite for dimethylsuccinate and N-
methylaspartate. These two dicarboxylate derivatives were
more potent in inhibiting ceNaDC1-mediated succinate uptake
than in inhibiting ceNaDC2-mediated succinate uptake.
The cDNA-specific succinate uptake was saturable for ceN-
aDC1 as well as for ceNaDC2, and the data conformed to the
Michaelis-Menten equation describing a single saturable sys-
tem (data not shown). The Michaelis-Menten constant (K
t
) was
0.73 0.05 m
M for ceNaDC1 and 60 9
M for ceNaDC2. Thus,
with succinate as the substrate, ceNaDC2 exhibits a 10-fold
greater affinity than ceINDY1. The competition studies sug-
gest that the same may be true for other dicarboxylate sub-
strates such as fumarate and malate. These data show that
FIG.2.Structure of cenadc1 and ce-
nadc2 genes. Exons are indicated by
filled boxes and numbered accordingly; in-
trons are shown by solid lines. The un-
translated regions in exons are indicated
by open boxes. The consensus polyadenyl-
ation signal AATAAA is also shown. Sizes
and positions of the exons and introns are
drawn to the exact scale.
FIG.3. A, ion dependence of ceNaDC-mediated succinate uptake in
HRPE cells. Uptake of 10
M succinate was measured in buffers con-
taining 140 m
M concentrations of sodium, lithium, potassium, or
NMDG (as chloride salts). Values represent means S.E. for four
determinations. Uptake of 10
M succinate measured in the vector
(pSPORT)-transfected cells served as a control for endogenous uptake
activity. The uptake in cDNA-transfected cells is given as percent of
uptake in vector-transfected cells. B, substrate specificity of the ceN-
aDC-mediated uptake. Uptake of 10
M [
3
H]succinate was measured in
the absence or presence of potential inhibitors (5 m
M) in cells trans-
fected with vector alone, ceNaDC1 cDNA, or ceNaDC2 cDNA. The
cDNA-specific uptake was calculated by adjusting for the uptake in
vector-transfected cells. The cDNA-specific uptake in the absence of
inhibitors was taken as the control (100%), and the uptake in the
presence of inhibitors is given as percent of this control value.
Sodium-coupled Dicarboxylate Transporters in C. elegans6140
by guest on December 22, 2015http://www.jbc.org/Downloaded from
ceNaDC1 is a low affinity Na
/succinate cotransporter, and
ceNaDC2 is a high affinity Na
/succinate cotransporter. There
-
fore, these two C. elegans dicarboxylate transporters corre-
spond at the functional level to mammalian NaDC1 and
NaDC3, respectively. NaCT shows very little ability to trans-
port succinate and thus is not related to either ceNaDC1 or
ceNaDC2 in terms of transport function. Drosophila INDY does
have the ability to transport various dicarboxylate intermedi-
ates of citric acid cycle (14, 15). But the transport function is
not Na
-dependent. Furthermore, Drosophila INDY has a
much higher affinity for citrate, a tricarboxylate, than for di-
carboxylates (14).
The effect of Na
on the uptake of succinate was then inves
-
tigated by measuring the uptake in the presence of varying
concentrations of extracellular Na
in cells transfected with
either ceNaDC1 cDNA or ceNaDC2 cDNA. Again, the uptake
values were adjusted for the endogenous uptake activity meas-
ured under identical conditions in cells transfected with vector
alone. The concentration of Na
in the uptake medium was
varied from 0 to 140 m
M. The osmolality of the medium was
maintained by adding appropriate concentrations of NMDG
chloride as a substitute for NaCl. The relationship between the
cDNA-specific uptake and Na
concentration was sigmoidal for
both ceNaDC1 and ceNaDC2, suggesting the involvement of
multiple Na
ions per succinate molecule transported. The
uptake rates failed to reach saturation within the concentra-
tion range of Na
employed in these studies.
Developmental Stage-specific Expression Pattern of ceNaDC1
mRNA and ceNaDC2 mRNATo monitor the relative expres-
sion levels of ceNaDC1 mRNA and ceNaDC2 mRNA during
different stages of C. elegans development, synchronized cul-
tures were obtained, and total RNA was isolated at each of the
following four stages of development: embryo, early larva (lar-
va stages 1 and 2), late larva (larva stages 3 and 4), and adult.
The steady state levels of mRNAs for ceNaDC1 and ceNaDC2
were then determined by semi-quantitative RT-PCR with 18 S
rRNA as an internal control for variations in RNA input into
RT-PCRs. The levels of ceNaDC1 mRNA and ceNaDC2 mRNA
were compared at different developmental stages based on
relative intensities of ceNaDC-specific RT-PCR products com-
pared with that of 18 S rRNA-specific RT-PCR product (Fig. 4).
ceNaDC1 mRNA expression was not detectable at the embryo
stage. Abundant expression of this mRNA was evident, how-
ever, at the early larva stage. There was a transient decrease in
ceNaDC1 mRNA levels at the late larva stage, but the levels
increased again during subsequent development into the adult
stage. The levels of ceNaDC1 mRNA as assessed by the relative
band intensities of RT-PCR products for ceNaDC1 and 18 S
rRNA at these four stages, namely embryo, early larva, late
larva, and adult, were 0, 0.87, 0.24, and 0.77. In the case of
ceNaDC2, the mRNA was below detectable levels in the em-
bryo, but the expression was easily detectable at the early larva
stage. The levels of mRNA reached the maximum at the late
larva stage. The relative mRNA levels for ceNaDC2 at the four
stages (embryo, early larva, late larva, and adult) were 0, 2.5,
4.2, and 3.7.
Tissue-specific Expression Pattern of cenadc1 and cenadc2
GenesWe first studied the tissue expression pattern of cen-
adc1 and cenadc2 genes in C. elegans using the transgenic GFP
fusion technique in which the transgene consisted of the cen-
FIG.4. Developmental stage-spe-
cific expression of ceNaDC1 and ceN-
aDC2. Following RT-PCR, 10
lofthe
products were separated in a 1.2% (w/v)
agarose gel to show the size and intensity
of the cenadc gene-specific and the 18 S
rRNA-specific fragments. A 1.0-kb DNA
marker (Invitrogen) was used as a molec-
ular mass standard. The upper bands
(850 bp long) were derived from the ce-
nadc1 (upper panel) and cenadc2 (lower
panel) transcripts; the lower bands (480
bp) were amplified from 18 S rRNA and
served as an internal control. The RNA
samples that served as templates were
prepared from different developmental
stages of C. elegans: embryos (Emb), early
larva stage (L1&2), late larva stage
(L3&4), and adults. In addition, RNA pre-
pared from a mixture of C. elegans at dif-
ferent developmental stages was also
used (Mix).
Sodium-coupled Dicarboxylate Transporters in C. elegans 6141
by guest on December 22, 2015http://www.jbc.org/Downloaded from
adc1 promoter fused with GFP cDNA or the cenadc2 promoter
fused with GFP cDNA. In both cases, the expression of GFP is
controlled by the respective promoter. Thus, the expression
pattern of GFP would match the expression pattern of the
cenadc1 and cenadc2 genes because of the control of the expres-
sion of the GFP reporter by the respective gene-specific pro-
moters. With this technique, we found that GFP expression is
restricted to the intestinal tract whether the expression of GFP
is driven by the ceNaDC1 promoter or by the ceNaDC2 pro-
moter (Fig. 5, A and B), indicating that both cenadc1 and
cenadc2 genes are expressed in the intestinal tract. The expres-
sion pattern is evident from the early larva stage through the
adult stage (data not shown). The GFP fluorescence is detect-
able throughout the intestinal tract, starting from the pharynx
all the way through the anus. In the case of both promoters, the
expression level of GFP is significantly greater in the anterior
half of the intestine than in the posterior half.
Because both cenadc1 and cenadc2 are expressed in the same
tissue, we employed a double-labeling approach to verify the
coexpression pattern of the two genes. In this approach, we
used two different fluorescent protein reporters, each driven
independently by either cenadc1 promoter (CFP) or cenadc2
promoter (YFP). Transgenic animals were developed that ex-
pressed both of the reporter constructs. The expression of CFP
as well as YFP was then examined in the same transgenic
animal under a fluorescence microscope with different excita-
tion and emission filter settings. These experiments showed
that the cenadc2 promoter-controlled YFP and the cenadc1
promoter-controlled CFP were coexpressed in the intestinal
tract (Fig. 5, C and D). This expression pattern was confirmed
with at least 10 transgenic animals.
Influence of RNAi-mediated Knockdown of the Function of
ceNaDC1 and ceNaDC2 on Average Life SpanThe knock-
down of the function of ceNaDC1 by feeding the wild type N2
worms on bacteria expressing the ceNaDC1-specific dsRNA did
not show any significant influence on average life span nor on
the maximal life span (Fig. 6). The average life span of these
worms was same as that of the worms fed on bacteria harboring
the empty vector pPD129 (pPD129 control, 15.3 days; ceNaDC1
knockdown, 14.8 days, p 0.05). In contrast, the knockdown of
the function of ceNaDC2 by feeding the wild type N2 worms on
bacteria expressing the ceNaDC2-specific dsRNA enhanced
significantly (p 0.0001) the average life span of the worms
(pPD129 control, 15.3 days; ceNaDC2 knockdown, 17.6 days).
The increase in average life span induced by ceNaDC2 knock-
down was 15%. We used DAF-2 knockdown as a positive control
in these experiments. Worms feeding on bacteria expressing
DAF-2-specific dsRNA exhibited an average life span of 30
days, showing that the knockdown of the function of DAF-2
doubles the average life span. This influence of DAF-2 knock-
down on life span is similar to the influence of homozygous
knockout of daf-2 gene function on life span (23, 24). This
attests to the validity of the experimental approach indicating
that the bacteria-mediated RNAi strategy is as effective as
homozygous knockout strategy.
DISCUSSION
We have described in this paper the cloning and functional
characterization of two transporters in C. elegans that mediate
the transport of several intermediates of the citric acid cycle.
Both transporters are Na
-coupled and exhibit broad substrate
specificity for dicarboxylates. They do not interact with mono-
carboxylates. At the functional level, these two transporters,
named ceNaDC1 and ceNaDC2, resemble the mammalian
Na
-coupled dicarboxylate transporters NaDC1 and NaDC3,
respectively.
Even though ceNaDC1 and ceNaDC2 generally resemble
NaDC1 and NaDC3, respectively, in terms of functional char-
acteristics, there is one important difference. This difference
relates to the interaction of these transporters with certain
derivatives of succinate such as dimethylsuccinate and
N-acetylaspartate. Dimethylsuccinate is considered to be a spe-
cific substrate for mammalian high affinity transporter NaDC3
(26, 27). The low affinity transporter NaDC1 does not tolerate
substitutions in the carbon backbone of succinate. Thus, di-
methylsuccinate and dimercaptosuccinate are recognized pref-
erentially by NaDC3. In contrast to the mammalian counter-
parts, it is ceNaDC1, the low affinity transporter in C. elegans,
that interacts with dimethylsuccinate with much higher affin-
ity compared with ceNaDC2. Interaction with N-acetylaspar-
FIG.5.Tissue-specific expression pattern of cenadc1 and cenadc2 genes. Expression of GFP was driven by the cenadc1 (A) and cenadc2
(B) gene promoters in stably transformed transgenic C. elegans. The insets A1 and B1 are the bright field images (low magnification) of the animals
for A and B, respectively. C, (YFP expression driven by the cenadc2 promoter) and D (CFP expression driven by the cenadc1 promoter) show the
expression pattern of YFP and CFP in the same animal. The inset C1/D1 is the bright field image of the same worm for both C and D.
Sodium-coupled Dicarboxylate Transporters in C. elegans6142
by guest on December 22, 2015http://www.jbc.org/Downloaded from
tate also follows a similar pattern. In mammals, NaDC3 shows
high affinity for this succinate analog (9). In contrast, it is
ceNaDC1, not ceNaDC2, that shows high affinity for this
compound.
Na
-activation kinetics of succinate uptake mediated by ce
-
NaDC1 and ceNaDC2 shows that multiple Na
ions are in
-
volved in the transport mechanism. Succinate exists as a diva-
lent anion under the experimental conditions (i.e. pH 7.5), and
therefore the number of Na
ions involved per transport cycle
will determine whether or not the transport process is influ-
enced by membrane potential. However, the exact number of
Na
ions transported with succinate per transport cycle could
not be determined in the present studies because the activation
of succinate uptake by Na
did not saturate within the range of
Na
concentrations employed in the study. We tried to express
ceNaDC1 and ceNaDC2 in Xenopus laevis oocytes to evaluate
the electrogenic nature of these two transporters by using the
two-microelectrode voltage clamp method, but the transporters
were not functionally expressed in this heterologous system.
We do not know the reasons for the lack of expression. We are
currently trying different expression vectors for this purpose.
Successful expression of these transporters in X. laevis oocytes
may become essential to demonstrate unequivocally whether or
not ceNaDCs are electrogenic.
In mammals, the expression of NaDC1 is restricted primar-
ily to the intestine and kidney, whereas the expression of
NaDC3 is evident not only in the intestine and kidney but also
in the liver, brain, and placenta (26). Furthermore, NaDC1 and
NaDC3 exhibit differential distribution in the apical versus
basolateral membrane of the polarized cells in the intestine,
kidney, liver, and placenta. NaDC1 is localized to the apical
membrane of the intestinal and renal tubular cells. In contrast,
NaDC3 is localized to the basolateral membrane of the renal
tubular cells, sinusoidal membrane of the hepatocytes, and the
brush border membrane of the placental syncytiotrophoblast
(26). The physiological function of NaDC1 in the intestine and
kidney is to facilitate the absorption of exogenous dicarboxy-
lates in the intestine and the reabsorption of endogenous di-
carboxylates in the kidney. In the liver and placenta, NaDC3
may play a role in the cellular entry of circulating dicarboxy-
lates for subsequent metabolic utilization. Because these dicar-
boxylates are present in the circulation only in micromolar
concentrations, the high affinity transporter NaDC3 has obvi-
ous advantages over the low affinity transporter NaDC1 to
perform this function. In C. elegans, the low affinity trans-
porter NaDC1 as well as the high affinity transporter NaDC2
are expressed predominantly in the intestinal tract. The C.
elegans intestinal tract is a tubular structure made up of a
single layer of 20 donut-shaped cells (28). Unlike in mammals,
the intestinal tract in C. elegans performs a variety of functions
in addition to the digestion and absorption of dietary nutrients.
It is a primary site of synthesis and storage of fat as the energy
source, a function similar to that of liver and adipose tissue in
mammals. The cells of the intestinal tract in C. elegans are
polarized, with numerous microvilli on the luminal surface
analogous to the apical membrane of the enterocytes in mam-
mals. The basolateral membrane of the intestinal cells is in
contact with the pseudocoelomic space that is filled with fluid
that supplies nutrients to the rest of the cells in the body. In
this respect, there is a lot of similarity between the intestinal
tract in C. elegans and the liver and adipose tissue in mam-
mals. We have provided evidence in this paper in support of
coexpression of NaDC1 and NaDC2 in the cells of the intestinal
tract in C. elegans. It is not known, however, whether these two
transporters are distributed differentially in the apical versus
basolateral membrane of the intestinal cells.
The physiological functions of NaDC1 and NaDC2 in C.
elegans intestinal tract are not known. We used the RNAi
technique to silence the function of these two transporters to
evaluate their influence on life span in this organism. This
technique is very effective in silencing the function of any
specific protein as evidenced by the doubling of the average life
span by silencing the function of DAF-2. Homozygous muta-
tions in daf-2 gene lead to doubling of life span in C. elegans
(23, 24). Since RNAi-mediated targeting of daf-2 also doubles
the life span, we conclude that this technique is very effective
in silencing the function of any targeted gene. RNAi-mediated
interference of NaDC1 function does not have any noticeable
effect on the average life span as well as on the maximal life
span, whereas targeting NaDC2 by this approach results in a
significant increase in the average and maximal life span. We
speculate that NaDC2 is localized to the basolateral membrane
of the intestinal cells where it functions in the cellular entry of
endogenous dicarboxylates for subsequent metabolic utiliza-
tion and energy production. Interference with this function
leads to a metabolic state analogous to that of caloric restric-
tion, thus resulting in life span extension. It has been well
established in C. elegans that caloric restriction (29) or sup-
pression of metabolic energy production within the mitochon-
dria (30) is associated with a significant increase in life span.
FIG.6.Influence of the knockdown
of ceNaDC1 and ceNaDC2 on life
span in C. elegans. The knockdown of
ceNaDC1 and ceNaDC2 was carried out
by feeding the worms with bacteria pro-
ducing ceNaDC1- or ceNaDC2-specific
dsRNA. The knockdown of DAF-2 was
used as a positive control. The survival
curves were plotted according to the
Kaplan-Meier algorithm using Sigma Plot
(version 6.0, SPSS Inc., Chicago). These
curves show the survival probability of
the wild type animals at a given day after
hatching under the influence of the gene-
specific dsRNAs. Each group was from a
total of four experiments. The total num-
ber of worms in each group at the begin-
ning of the life span experiment was 240.
Sodium-coupled Dicarboxylate Transporters in C. elegans 6143
by guest on December 22, 2015http://www.jbc.org/Downloaded from
It is interesting to note that Indy gene is expressed in Dro-
sophila in tissues such as the fat body, midgut, and oenocytes
(12, 15). The fat body in this organism is involved in the
metabolism and storage of major energy sources (fat, glycogen,
and protein). The metabolic functions of this organ are similar
to those of liver in mammals. The same is true with the intes-
tinal tract in C. elegans where NaDC2 expression is seen.
However, the transport characteristics of ceNaDC2 are very
different from those of Drosophila INDY even though disrup-
tion of NaDC2 function enhances life span in C. elegans as
disruption of INDY does in Drosophila. In addition to NaDC1
and NaDC2 reported in this paper, a recent search of the C.
elegans data base has revealed that there are three other genes
coding for putative transporters with structural similarity to
Drosophila INDY. Cloning and functional characterization of
these putative transporters will be required to establish the
molecular identity of the gene that is the C. elegans functional
counterpart of Drosophila INDY. The present studies have
clearly shown that NaDC2 is involved in the regulation of life
span in C. elegans, but it is likely that additional transporters
with NaDC2-like transport function may exist in this organism
and function in the regulation of life span.
REFERENCES
1. Pajor, A. M. (1995) J. Biol. Chem. 270, 5779 5785
2. Pajor, A. M., and Sun, N. (1996) Am. J. Physiol. 271, F1093F1099
3. Sekine, T., Cha, S. H., Hosoyamada, M., Kanai, Y., Watanabe, N., Furuta, Y.,
Fukuda, K., Igarashi, T., and Endou, H. (1998) Am. J. Physiol. 275,
F298 F305
4. Chen, X. Z., Shayakul, C., Berger, U. V., Tian, W., and Hediger, M. A. (1998)
J. Biol. Chem. 273, 2097220981
5. Kekuda, R., Wang, H., Huang, W., Pajor, A. M., Leibach, F. H., Devoe, L. D.,
Prasad, P. D., and Ganapathy, V. (1999) J. Biol. Chem. 274, 34223429
6. Chen, X., Tsukaguchi, H., Chen, X. Z., Berger, U. V., and Hediger, M. A. (1999)
J. Clin. Invest. 103, 1159 1168
7. Wang, H., Fei, Y. J., Kekuda, R., Yang-Feng, T. L., Devoe, L. D., Leibach, F. H.,
Prasad, P. D., and Ganapathy, V. (2000) Am. J. Physiol. 278, C1019C1030
8. Russel, F. G., Masereeuw, R., and van Aubel, R. A. (2002) Annu. Rev. Physiol.
64, 563594
9. Huang, W., Wang, H., Kekuda, R., Fei, Y. J., Friedrich, A., Wang, J., Conway,
S. J., Cameron, R. S., Leibach, F. H., and Ganapathy, V. (2000) J. Pharma-
col. Exp. Ther. 295, 392 403
10. Inoue, K., Zhuang, L., Maddox, D. M., Smith, S. B., and Ganapathy, V. (2002)
J. Biol. Chem. 277, 39469 39476
11. Inoue, K., Zhuang, L., and Ganapathy, V. (2002) Biochem. Biophys. Res.
Commun. 299, 465 471
12. Rogina, B., Reenan, R. A., Nilsen, S. P., and Helfand, S. L. (2000) Science 290,
21372140
13. Sohal, R. S., and Weindruch, R. (1996) Science 273, 59 63
14. Inoue, K., Fei, Y. J., Huang, W., Zhuang, L., Chen, Z., and Ganapathy, V.
(2002) Biochem. J. 317, 313319
15. Knauf, F., Rogina, B., Jiang, Z., Aronson, P. S., and Helfand, S. L. (2002) Proc.
Natl. Acad. Sci. U. S. A. 99, 1431514319
16. Fei, Y. J., Fujita, T., Lapp, D. F., Ganapathy, V., and Leibach, F. H. (1998)
Biochem. J. 332, 565572
17. Fei, Y. J., Romero, M. F., Krause, M., Liu, J. C., Huang, W., Ganapathy, V., and
Leibach, F. H. (2000) J. Biol. Chem. 275, 95639571
18. Lewis, J. A., and Fleming, J. T. (1995) Methods Cell Biol. 48, 329
19. Wood, W. B. (1988) in The Nematode Caenorhabditis elegans (Wood, W. B., and
the Community of C. elegans Researchers, eds) pp. 587 606, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY
20. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual, pp. 9.319.50, 2nd Ed., Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY
21. Anderson, P. (1995) Methods Cell Biol. 48, 3158
22. Miller, D. M., III, Desai, N. S., Hardin, D. C., Piston, D. W., Patterson, G. H.,
Fleenor, J., Xu, S., and Fire, A. (1999) BioTechniques 26, 914 921
23. Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993) Nature
366, 461 464
24. Wolkow, C. A., Kimura, K. D., Lee, M. S., and Ruvkun, G. (2000) Science 290,
147150
25. Davies, J. P., Yildiz, F. H., and Grossman, A. (1996) EMBO J. 15, 2150 2159
26. Pajor, A. M. (2000) J. Membr. Biol. 175, 1 8
27. Ullrich, K. J. (1997) J. Membr. Biol. 158, 95107
28. Avery, L., and Thomas, J. H. (1997) in C. elegans II (Riddle, D. L., Blumenthal,
T., Meyer, B. J., and Priess, J. R., eds) pp. 679 716, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY
29. Lakowski, B., and Hekimi, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95,
1309113096
30. Larsen, P. L., and Clarke, C. F. (2002) Science 295, 120 123
Sodium-coupled Dicarboxylate Transporters in C. elegans6144
by guest on December 22, 2015http://www.jbc.org/Downloaded from
Ganapathy
You-Jun Fei, Katsuhisa Inoue and Vadivel
Relevance to Life Span
and TheirCaenorhabditis elegansfrom
Transporters (ceNaDC1 and ceNaDC2)
of Two Sodium-coupled Dicarboxylate
Structural and Functional Characteristics
FUNCTION AND BIOGENESIS:
MEMBRANE TRANSPORT STRUCTURE
doi: 10.1074/jbc.M208763200 originally published online December 11, 2002
2003, 278:6136-6144.J. Biol. Chem.
10.1074/jbc.M208763200Access the most updated version of this article at doi:
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the
Alerts:
When a correction for this article is posted
When this article is cited
to choose from all of JBC's e-mail alertsClick here
http://www.jbc.org/content/278/8/6136.full.html#ref-list-1
This article cites 27 references, 13 of which can be accessed free at
by guest on December 22, 2015http://www.jbc.org/Downloaded from
... Similarly, reduced levels of Indy, which functions as a cation-independent electroneutral transporter for a variety of di/tricarboxylic acid-cycle intermediates, extended lifespan in Drosophila (Rogina et al., 2000). Downregulation of worm ortholog of Indy -ceNAC-1/ceNaDC1 (corresponding to mammalian NaDC1/NaC1) did not affect worm lifespan, while downregulation of ceNAC-3/ceNaDC2 (corresponding to mammalian NaDC3/NaC3) increased worm lifespan by 15%, and downregulation of ceNAC-2/NaCT (mammalian NaC2/NaC2) increased worm lifespan by 19% (Fei et al., 2003;Fei et al., 2004). Moreover, a knockout mouse model of the mammalian Indy (mIndy) ortholog, SLC13A5, phenocopies the DR-like phenotype and protects mINDY-deficient mice from the adiposity and insulin resistance that normally result from a high-fat diet and aging (Birkenfeld et al., 2011). ...
... , (Hansen et al., 2005) (Gusarov et al., 2017), (Seo et (Honda et al., 2010), (Seo et al., 2018) (Mouchiroud et al., 2011), (Butler et al., 2013;Mishur et al., 2016) (Fei et al., 2003;Fei et al., 2004) ceNAC-2/NaCT ceNAC-2/NaCT Mitochondria l transporter Downregulation 19% increase (Fei et al., 2003;Fei et al., 2004) ...
... , (Hansen et al., 2005) (Gusarov et al., 2017), (Seo et (Honda et al., 2010), (Seo et al., 2018) (Mouchiroud et al., 2011), (Butler et al., 2013;Mishur et al., 2016) (Fei et al., 2003;Fei et al., 2004) ceNAC-2/NaCT ceNAC-2/NaCT Mitochondria l transporter Downregulation 19% increase (Fei et al., 2003;Fei et al., 2004) ...
Article
Metabolism plays a significant role in the regulation of aging at different levels, and metabolic reprogramming represents a major driving force in aging. Metabolic reprogramming leads to impaired organismal fitness, an age-dependent increase in susceptibility to diseases, decreased ability to mount a stress response, and increased frailty. The complexity of age-dependent metabolic reprogramming comes from the multitude of levels on which metabolic changes can be connected to aging and regulation of lifespan. This is further complicated by the different metabolic requirements of various tissues, cross-organ communication via metabolite secretion, and direct effects of metabolites on epigenetic state and redox regulation; however, not all of these changes are causative to aging. Studies in yeast, flies, worms, and mice have played a crucial role in identifying mechanistic links between observed changes in various metabolic traits and their effects on lifespan. Here, we review how changes in the organismal and organ-specific metabolome are associated with aging and how targeting of any one of over a hundred different targets in specific metabolic pathways can extend lifespan. An important corollary is that restriction or supplementation of different metabolites can change activity of these metabolic pathways in ways that improve healthspan and extend lifespan in different organisms. Due to the high levels of conservation of metabolism in general, translating findings from model systems to human beings will allow for the development of effective strategies for human health- and lifespan extension.
... The transport domain from vertebrate or lower eukaryotic organisms contains two Ser-Asn-Thr/Val (SNT-SNT/V) motifs, which were regarded as signature sequences of SLC13 family proteins (Mancusso et al., 2012). Functionally, most SLC13 proteins from mammals and bacteria typically are found to couple Na + to move an anion substrate such as organic di-/tricarboxylates and inorganic sulfate (Beck & Markovich, 2000;Fei et al., 2003;Estrella et al., 2008;Bergeron et al., 2013); however, some members from insects and plants are Na + -independent exchangers (Inoue et al., 2002) or H + -coupled symporters (Emmerlich et al., 2003). At present, the focus of SLC13 family research was mainly on vertebrate and lower eukaryotic members. ...
... SLC13 members. First, in contrast to the dependence of the vertebrate and lower eukaryotic SLC13 transporters on Na + (Fei et al., 2003;Hall & Pajor, 2005Strickler et al., 2009), PvAsE1 exhibited CCCP-inhibitable As transport, indicating that it might be a H + coupled transporter. Another difference is the SLC13 significant sequence. ...
Article
Full-text available
Pteris vittata is an arsenic (As) hyperaccumulator that can accumulate several thousand mg As kg⁻¹ DW in aboveground biomass. A key factor for its hyperaccumulation ability is its highly efficient As long‐distance translocation system. However, the underlying molecular mechanisms remain unknown. We isolated PvAsE1 through the full‐length cDNA over‐expression library of P. vittata and characterized it through a yeast system, RNAi gametophytes and sporophytes, subcellular‐location and in situ hybridization. Phylogenomic analysis was conducted to estimate the appearance time of PvAsE1. PvAsE1 was a plasma membrane‐oriented arsenite (AsIII) effluxer. The silencing of PvAsE1 reduced AsIII long‐distance translocation in P. vittata sporophytes. PvAsE1 was structurally similar to solute carrier (SLC)13 proteins. Its transcripts could be observed in parenchyma cells surrounding the xylem of roots. The appearance time was estimated at c. 52.7 Ma. PvAsE1 was a previously uncharacterized SLC13‐like AsIII effluxer, which may contribute to AsIII long‐distance translocation via xylem loading. PvAsE1 appeared late in fern evolution and might be an adaptive subject to the selection pressure at the Cretaceaou–Paleogene boundary. The identification of PvAsE1 provides clues for revealing the special As hyperaccumulation characteristics of P. vittata.
... This is illustrated by studies that show similar effects of Indy reduction on metabolism in flies, worms, mice, rats, non-human primates and humans [10][11][12]. Reducing Indy gene expression levels extends longevity in flies and worms by affecting multiple metabolic pathways [1,10,[13][14][15][16][17]. In this review, we focus on the effects of reduced INDY activity on metabolism, mitochondrial biogenesis and fly stem ...
... In flies, the INDY protein is predominantly expressed on the plasma membrane of metabolic tissues-the midgut, fat body, and oenocytes-all of which play an important role in uptake and storage of nutrients and energy production [1,2]. The worm homologues of INDY are predominantly expressed in the intestinal tract [15]. Mammalian mINDY is expressed at high levels in liver, brain, and testis, while low levels are found in heart, kidney, bones, and ovary in humans, mice, and rats [10,[18][19][20]. ...
Article
Full-text available
I’m Not Dead Yet (Indy) is a fly gene that encodes a homologue of mammalian SLC13A5 plasma membrane citrate transporter. Reducing expression of Indy gene in flies, and its homologues in worms, extends longevity. Indy reduction in flies, worms, mice and rats affects metabolism by regulating the levels of cytoplasmic citrate, inducing a state similar to calorie restriction. Changes include lower lipid levels, increased insulin sensitivity, increased mitochondrial biogenesis, and prevention of weight gain, among others. The INDY protein is predominantly expressed in fly metabolic tissues: the midgut, fat body and oenocytes. Changes in fly midgut metabolism associated with reduced Indy gene activity lead to preserved mitochondrial function and reduced production of reactive oxygen species. All these changes lead to preserved intestinal stem cell homeostasis, which has a key role in maintaining intestinal epithelium function and enhancing fly healthspan and lifespan. Indy gene expression levels change in response to caloric content of the diet, inflammation and aging, suggesting that INDY regulates metabolic adaptation to nutrition or energetic requirements by controlling citrate levels.
... Reduced expression of the Indy gene in flies and worms extends longevity in all but one study (Rogina et al., 2000;Fei et al., 2003Fei et al., , 2004Toivonen et al., 2007;Wang et al., 2009;Rogina and Helfand, 2013;Rogers and Rogina, 2014;Schwarz et al., 2015). INDY is expressed on the plasma membrane of metabolically active tissues. ...
... In humans, Indy mRNA is mainly expressed in the liver, less in the brain and testis, while small levels of Indy mRNA expression were found in the kidneys, thymus, ovaries, adipose tissue, stomach, and colon (Inoue et al., 2002b;von Loeffelholz et al., 2017). Decreased expression of Indy in worms, flies, mice, and rats alters metabolism in a manner similar to calorie restriction (CR; Rogina et al., 2000;Fei et al., 2003;Bross et al., 2005;Neretti et al., 2009;Wang et al., 2009;Birkenfeld et al., 2011;Schwarz et al., 2015). This is supported by similar phenotypes found in CR wild type flies and in Indy flies that were kept on a high calorie diet. ...
Article
Full-text available
The Indy (I’m Not Dead Yet) gene encodes the fly homolog of the mammalian SLC13A5 citrate transporter. Reduced expression of the Indy gene in flies and worms extends their longevity. INDY is expressed in the plasma membrane of metabolically active tissues. Decreased expression of Indy in worms, flies, mice, and rats alters metabolism in a manner similar to calorie restriction. Reducing INDY activity prevents weight gain in flies, worms, and mice, and counteracts the negative effects of age or a high fat diet on metabolism and insulin sensitivity. The metabolic effects of reducing INDY activity are the result of reduced cytoplasmic citrate. Citrate is a key metabolite and has a central role in energy status of the cell by effecting lipid and carbohydrate metabolism and energy production. Thereby newly described drugs that reduce INDY transporting activity increase insulin sensitivity and reduce hepatic lipid levels via its effect on hepatic citrate uptake. A recent report presented the first direct link between increased hepatic levels of human INDY, insulin resistance, and non-alcoholic fatty liver disease in obese humans. Similarly increased hepatic mIndy levels were observed in non-human primates fed on a high fat diet for 2 years. This effect is mediated via the stimulatory effect of the interleukin-6/Stat3 pathway on mINDY hepatic expression. These findings make INDY a potential and very promising target for the treatment of metabolic disorders in humans.
... While the neurologic phenotype has been described in a mouse model with loss of SLC13A5, a variety of animal models also show robust non-neurologic phenotypes. Reduced expression of SLC13A5, I am Not Dead Yet (INDY), in flies and worms increases lifespan and decreases whole-body fat [11][12][13]. Mice lacking SLC13A5 show increased propensity for seizures as part of the neurologic phenotype [14]. In addition to a neurologic phenotype, loss of SLC13A5 in mice reduces growth parameters such as weight and length [15,16]. ...
Article
Full-text available
We were interested in elucidating the non-neurologic health of patients with autosomal recessive SLC13A5 Citrate Transporter (NaCT) Disorder. Multiple variants have been reported that cause a loss of transporter activity, resulting in significant neurologic impairment, including seizures, as well as motor and cognitive dysfunction. Additionally, most patients lack tooth enamel (amelogenesis imperfecta). However, patients have not had their overall health and growth described in detail. Here we characterized the non-neurologic health of 15 patients with medical records uploaded to Ciitizen, a cloud-based patient medical records portal. Ciitizen used a query method for data extraction. Overall, the patients’ records suggested a moderate number of gastrointestinal issues related to feeding, reflux, vomiting and weight gain and a diverse number of respiratory complaints. Other organ systems had single or no abnormal diagnoses, including liver, renal and cardiac. Growth parameters were mostly in the normal range during early life, with a trend toward slower growth in the few adolescent patients with data available. The gastrointestinal and pulmonary issues may at least partially be explained by the severity of the neurologic disorder. More data are needed to clarify if growth is impacted during adolescence and if adult patients develop or are protected from non-neurologic disorders.
... For example, a number of mutations in a DASS-encoding gene had been found to nearly double the average adult life-span in fruit flies, likely by promoting a metabolic state that mimics caloric and dietary restriction [17,18]. In addition, the knockdown of the genes encoding NaDC2 and NaCT in worms could decrease their body size and fat content, and/or increase their life span [19,20]. Moreover, the deletion of the gene encoding NaCT protected mice from the adiposity and insulin resistance induced by high-fat feeding and aging [21]. ...
Article
Full-text available
Integral membrane proteins of the divalent anion/Na+ symporter (DASS) family are conserved from bacteria to humans. DASS proteins typically mediate the coupled uptake of Na+ ions and dicarboxylate, tricarboxylate, or sulfate. Since the substrates for DASS include key intermediates and regulators of energy metabolism, alterations of DASS function profoundly affect fat storage, energy expenditure and life span. Furthermore, loss-of-function mutations in a human DASS have been associated with neonatal epileptic encephalopathy. More recently, human DASS has also been implicated in the development of liver cancers. Therefore, human DASS proteins are potentially promising pharmacological targets for battling obesity, diabetes, kidney stone, fatty liver, as well as other metabolic and neurological disorders. Despite its clinical relevance, the mechanism by which DASS proteins recognize and transport anionic substrates remains unclear. Recently, the crystal structures of a bacterial DASS and its humanized variant have been published. This article reviews the mechanistic implications of these structures and suggests future work to better understand how the function of DASS can be modulated for potential therapeutic benefit.
... C. elegans with reduced Indy expression exhibited lower lipid content, as shown by two independent groups, while one group failed to observe this phenotype Schwarz et al., 2015;Toivonen et al., 2007). The C. elegans Indy homolog CeNac2 is expressed mainly in tissues functioning as sites of nutrient absorption and fat storage (Fei, Inoue, & Ganapathy, 2003;Knauf, Rogina, Jiang, Aronson, & Helfand, 2002;Wang et al., 2009). CeNac2 is also located on the plasma membrane and transports TCA cycle intermediates, which are used to generate biochemical energy in the form of ATP. ...
Article
Full-text available
The regulation of metabolic processes by the Indy (I′m Not Dead Yet) (SLC13A5/NaCT) gene was revealed through studies in Drosophila melanogaster and Caenorhabditis elegans. Reducing the expression of Indy in these species extended their life span by a mechanism resembling caloric restriction, without reducing food intake. In D. melanogaster, mutating the Indy gene reduced body fat content, insulin-like proteins and reactive oxygen species production. Subsequent studies indicated that Indy encodes a citrate transporter located on the cell plasma membrane. The transporter is highly expressed in the mammalian liver. We generated a mammalian knock out model deleting the mammalian homolog mIndy (SLC13A5). The knock out animals were protected from HFD induced obesity, fatty liver and insulin resistance. Moreover, we have shown that inducible and liver selective knock down of mIndy protects against the development of fatty liver and insulin resistance and that obese humans with type 2 diabetes and non-alcoholic fatty liver disease have increased levels of mIndy. Therefore, the transporter mINDY (NaCT) has been proposed to be an ‘ideal target for the treatment of metabolic disease’. A small molecule inhibitor of the mINDY transporter has been generated, normalizing glucose Levels and reducing fatty liver in a model of diet induced obese mice. Taken together, studies from lower organisms, mammals and humans suggest that mINDY (NaCT) is an attractive target for the treatment of metabolic disease.
... C. elegans with reduced Indy expression exhibited lower lipid content, as shown by two independent groups, while one group failed to observe this phenotype Schwarz et al., 2015;Toivonen et al., 2007). The C. elegans Indy homolog CeNac2 is expressed mainly in tissues functioning as sites of nutrient absorption and fat storage (Fei, Inoue, & Ganapathy, 2003;Knauf, Rogina, Jiang, Aronson, & Helfand, 2002;Wang et al., 2009). CeNac2 is also located on the plasma membrane and transports TCA cycle intermediates, which are used to generate biochemical energy in the form of ATP. ...
Article
Full-text available
The regulation of metabolic processes by the Indy (I'm Not Dead Yet) (SLC13A5/NaCT) gene was revealed through studies in Drosophila melanogaster and Caenorhabditis elegans. Reducing the expression of Indy in these species extended their life span by a mechanism resembling caloric restriction, without reducing food intake. In D. melanogaster, mutating the Indy gene reduced body fat content, insulin-like proteins and reactive oxygen species production. Subsequent studies indicated that Indy encodes a citrate transporter located on the cell plasma membrane. The transporter is highly expressed in the mammalian liver. We generated a mammalian knock out model deleting the mammalian homolog mIndy (SLC13A5). The knock out animals were protected from HFD induced obesity, fatty liver and insulin resistance. Moreover, we have shown that inducible and liver selective knock down of mIndy protects against the development of fatty liver and insulin resistance and that obese humans with type 2 diabetes and non-alcoholic fatty liver disease have increased levels of mIndy. Therefore, the transporter mINDY (NaCT) has been proposed to be an 'ideal target for the treatment of metabolic disease'. A small molecule inhibitor of the mINDY transporter has been generated, normalizing glucose levels and reducing fatty liver in a model of diet induced obese mice. Taken together, studies from lower organisms, mammals and humans suggest that mINDY (NaCT) is an attractive target for the treatment of metabolic disease.
... Particularly, a handful of mutations found in a DASS-encoding gene nearly doubled the average adult life span in fruit flies, likely by promoting a metabolic state that mimics caloric and dietary restriction 14,15 . In addition, the knockdown of either one of the genes encoding NaDC2 and NaCT in worms decreased their body size and fat content, and/or increased their life span 16,17 . More recently, deletion of the gene-encoding NaCT protected mice from the adiposity and insulin resistance induced by high-fat feeding and aging 18 . ...
Article
Full-text available
Integral membrane proteins of the divalent anion/Na+ symporter (DASS) family translocate dicarboxylate, tricarboxylate or sulphate across cell membranes, typically by utilizing the preexisting Na+ gradient. The molecular determinants for substrate recognition by DASS remain obscure, largely owing to the absence of any substrate-bound DASS structure. Here we present 2.8-Å resolution X-ray structures of VcINDY, a DASS from Vibrio cholerae that catalyses the co-transport of Na+ and succinate. These structures portray the Na+-bound VcINDY in complexes with succinate and citrate, elucidating the binding sites for substrate and two Na+ ions. Furthermore, we report the structures of a humanized variant of VcINDY in complexes with succinate and citrate, which predict how a human citrate-transporting DASS may interact with its bound substrate. Our findings provide insights into metabolite transport by DASS, establishing a molecular basis for future studies on the regulation of this transport process.
Article
How diatoms respond to fluctuations in osmotic pressure is important from both ecological and applied perspectives. It is well known that osmotic stress affects photosynthesis and can result in the accumulation of compounds desirable in pharmaceutical and alternative fuel industries. Gene expression responses to osmotic stress have been studied in short term trials, but it is unclear whether the same mechanisms are recruited during long‐term acclimation. We used RNA‐seq to study the genome‐wide transcription patterns in the euryhaline diatom, Cyclotella cryptica following long‐term acclimation to salinity that spanned the natural range of fresh to oceanic water. Long‐term acclimated C. cryptica exhibited induced synthesis or repressed degradation of the osmolytes glycine betaine, taurine, and dimethylsulfoniopropionate (DMSP). Although changes in proline concentration is one of the main responses in short‐term osmotic stress, we did not detect a transcriptional change in proline biosynthetic pathways in our long‐term experiment. Expression of membrane transporters showed a general tendency for increased import of potassium and export of sodium, consistent with the electrochemical gradients and dependence on co‐transported molecules. Our results show substantial between‐genotype differences in growth and gene expression reaction norms and suggest that the regulation of proline synthesis important in short‐term osmotic stress might not be maintained in long‐term acclimation. Further examination using time‐course gene expression experiments, metabolomics, and genetic validation of gene functions would reinforce patterns inferred from RNA‐seq data.
Article
Full-text available
The cDNA coding for a rabbit renal Na+/dicarboxylate cotransporter, designated NaDC-1, was isolated by functional expression in Xenopus oocytes. NaDC-1 cDNA is approximately 2.3 kilobases in length and codes for a protein of 593 amino acids. NaDC-1 protein contains eight putative transmembrane domains, and the sequence and secondary structure are related to the renal Na+/sulfate transporter, NaSi-1. Northern analysis shows that the NaDC-1 message is abundant in kidney and small intestine, and related transporters may be found in liver, lung, and adrenal. The transport of succinate by NaDC-1 was sodium-dependent, sensitive to inhibition by lithium, and inhibited by a range of di- and tricarboxylic acids. This transporter also carries citrate, but it does not transport lactate. In kinetic experiments, the Km for succinate was around 0.4 mM and the Vmax was 15 nmol/oocyte/h, while the Hill coefficient of Na+ activation of succinate transport was 1.9. The transport of succinate by NaDC-1 was insensitive to changes in pH, whereas the transport of citrate increased with decreasing pH, in parallel with the concentration of divalent citrate in the medium. The results of the functional characterization indicate that NaDC-1 likely corresponds to the renal brush-border Na+/dicarboxylate cotransporter.
Article
Full-text available
The sac1 mutant of Chlamydomonas reinhardtii is aberrant in most of the normal responses to sulfur limitation; it cannot synthesize arylsulfatase, does not take up sulfate as rapidly as wild-type cells, and does not synthesize periplasmic proteins that normally accumulate during sulfur-limited growth. Here, we show that the sac1 mutant dies much more rapidly than wild-type cells during sulfur deprivation; this emphasizes the vital role of the acclimation process. The loss of viability of the sac1 mutant during sulfur deprivation is only observed in the light and is mostly inhibited by DCMU. During sulfur-stress, wild-type cells, but not the sac1 mutant, downregulate photosynthesis. Thus, death of the sac1 mutant during sulfur deprivation is probably a consequence of its inability to downregulate photosynthesis. Furthermore, since SAC1 is necessary for the downregulation of photosynthesis, the process must be highly controlled and not simply the result of a general decrease in protein synthesis due to sulfur limitation. Genomic and cDNA copies of the SAC1 gene have been cloned. The deduced amino acid sequence of Sac1 is similar to an Escherichia coli gene that may involved in the response of E.coli to nutrient deprivation.
Article
Full-text available
Under normal physiological conditions, the use of oxygen by cells of aerobic organisms generates potentially deleterious reactive oxygen metabolites. A chronic state of oxidative stress exists in cells because of an imbalance between prooxidants and antioxidants. The amount of oxidative damage increases as an organism ages and is postulated to be a major causal factor of senescence. Support for this hypothesis includes the following observations: (i) Overexpression of antioxidative enzymes retards the age-related accrual of oxidative damage and extends the maximum life-span of transgenic Drosophila melanogaster. (ii) Variations in longevity among different species inversely correlate with the rates of mitochondrial generation of the superoxide anion radical (O·−2) and hydrogen peroxide. (iii) Restriction of caloric intake lowers steady-state levels of oxidative stress and damage, retards age-associated changes, and extends the maximum life-span in mammals.
Article
This chapter discusses the principles and protocols involved in mutagenesis of Caenorhabditis elegans. Intended as a guide to the choice of mutagens and elaborates basic principles for their rational use this chapter considers only mutagenesis related to “forward” genetic analysis. “Forward” in this context means the identification of mutant strains following global mutagenesis of the entire genome. The goal of in vivo mutagenesis is to increase either the frequency or the variety of mutations contained in a population of animals. The benefit of increasing the frequency of mutations is self-evident; it makes finding the desired mutants easier. Choosing the right mutagen means selecting the right combination of mutagen efficiency and mutagen specificity. For mutagen efficiency, nothing beats Ethyl methanesulfate (EMS). It is extremely potent, easy to use, and its mutational specificity is well documented. If mutations other than G/C →A/T transitions are desired, mutagens other than EMS must be used. Based on initial observations, N-nitroso-N-ethylurea (ENU) appears to be as efficient as EMS.
Article
This chapter discusses the basic culture methods of the Caenorhabditis elegans (C. elegans) system. The nematode C. elegans is a small, rapidly growing organism that can easily be raised in the laboratory on the bacterium Escherichia coli. Because C. elegans is a self-fertilizing hermaphrodite, it is possible to grow large quantities of the organism in swirling liquid cultures, and possible to propagate severely incapacitated mutants. The rapidity of growth and the ability to self-fertilize necessitate special measures to establish a synchronous culture. C. elegans grows rapidly and is most fecund at 20°C. Growth at 16 and 25°C provides some control over the rate of growth and the facility to work with temperature-sensitive mutants. Gram quantities of nematodes can be prepared by growth on petri plates, or by rotary shaking in a flask at controlled temperatures. Petri plate methods are economical and require no special equipment. Large quantities of nematodes are more easily prepared in fermentor-like devices. Fementors offer the advantage of scalability, minimizing the number of parallel cultures required to grow a large quantity of worms.
Article
We have found that mutations in the gene daf-2 can cause fertile, active, adult Caenorhabditis elegans hermaphrodites to live more than twice as long as wild type. This lifespan extension, the largest yet reported in any organism, requires the activity of a second gene, daf-16. Both genes also regulate formation of the dauer larva, a developmentally arrested larval form that is induced by crowding and starvation and is very long-lived. Our findings raise the possibility that the longevity of the dauer is not simply a consequence of its arrested growth, but instead results from a regulated lifespan extension mechanism that can be uncoupled from other aspects of dauer formation. daf-2 and daf-16 provide entry points into understanding how lifespan can be extended.
Article
Polyclonal antibodies were prepared against the rabbit renal Na(+)-dicarboxylate cotransporter, NaDC-1. The antibodies were raised in chickens against a fusion protein consisting of a 60-amino acid peptide from NaDC-1 and glutathione S-transferase. These antibodies specifically recognized the fusion protein in Western blots and could immunoprecipitate the full-length NaDC-1 after in vitro translation. The antifusion protein antibodies specifically recognized a protein of 63 kDa in rabbit renal brush-border membrane vesicles (BBMV), similar to the predicted mass of 66 kDa. Two proteins of 57 and 115 kDa were recognized in rabbit intestinal brush-border membranes. A protein of 66 kDa was recognized in Xenopus oocytes injected with NaDC-1 cRNA. Enzymatic deglycosylation of rabbit renal BBMV resulted in a decrease in mass by 11 kDa, consistent with N-glycosylation at a single site. Site-directed mutagenesis of the two consensus sequences for N-glycosylation in the NaDC-1 cDNA showed that Asn-576, located near the COOH-terminal, is glycosylated. The nonglycosylated mutant of NaDC-1 exhibited 50% of wild-type succinate transport activity when expressed in Xenopus oocytes, suggesting that glycosylation is not essential for function. The revised secondary structure model of NaDC-1 contains 11 putative transmembrane domains and an extracellular glycosylated COOH-terminal.